Trusted in times of crisis, Peroxigard™, formulated with Accelerated Hydrogen Peroxide® is approved for use against SARS-CoV-2, the virus that causes COVID-19 when used in accordance with the directions for use against Poliovirus type 1. For Peroxigard Concentrate use a 1:64 dilution and contact time 5 minutes and a contact time of 1 minute for Peroxigard™ RTU and Wipes.
For further information, please review our formal press release below:
[wonderplugin_pdf src="https://peroxigard-us.bold-staging.com/wp-content/uploads/2020/01/Peroxigard-US-efficacy-against-SARS-CoV-2_April-13-003.pdf" width="100%" height="1050px" style="border:0;"] |